A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - FR0010557264 - AB) announces ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy with a poor prognosis for patients. Disulfidptosis response-related long non-coding RNAs (DRLs) have been demonstrated to be ...

Breakthroughs in combination drug-therapies, including BCL2 protein inhibitors and FLT3 gene inhibitors, are offering dramatically improved responses. Since 2012, when acute myeloid leukemia (AML) ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk of the disease, a study in mice has suggested. Further research in clinical ...

Recovery after a stem-cell transplant typically requires a hospital stay of several weeks. Recipients may experience side effects. If you or a loved one has been diagnosed with Acute Myeloid Leukemia ...

Recent advancements in multi-omics technology have generated significant interest in exploring the role of gut microbiota in the treatment and prognosis of acute myeloid leukemia (AML). Research ...